Merck Sharp & Dohme Corp.
Legislative Bill Tracking
2022


BillBill Title & Upcoming Hearing DateSponsorStatusPosition
HB 5042 An Act Concerning Health Care Cost Growth.

REQUEST OF THE GOVERNOR PURSUANT TO JOINT RULE 9
Referred to Joint Committee on Insurance and Real Estate (2/10)
HB 5126 An Act Concerning The Bioscience Industry.

02/22/22 11:30 AM in CE
Commerce
CE Public Hearing: Tue 2/22 11:30 AM @ (2/17)
HB 5149 An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Food, Drugs And Medical Devices.

02/22/22 10:00 AM in GL
General Law
Referred to Joint Committee on General Law (2/17)
SB 13 An Act Reducing Prescription Drug Prices.

REQUEST OF THE GOVERNOR PURSUANT TO JOINT RULE 9
Referred to Joint Committee on Insurance and Real Estate (2/10)
SB 34 An Act Concerning Funding For The Covered Connecticut Program.

Sen. Matthew L. Lesser (S9)
Referred to Joint Committee on Appropriations (2/15)
SB 80 An Act Concerning Federal Reimbursements For Certain Pharmaceutical Purchases.

Sen. Catherine A. Osten (S19)
Referred to Joint Committee on Veterans' Affairs (2/15)
SB 136 An Act Increasing The Bond Authorization For The Connecticut Bioscience Innovation Fund.

Sen. Tony Hwang (S28)
Referred to Joint Committee on Finance, Revenue and Bonding (2/18)